Skip to content
STTKShattuck Labs, Inc.

Earnings

When Shattuck Labs, Inc. reports, what it reported each quarter, and how the stock took the results.

31 quarters. Mar 31, 2019 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Mar 4, before the open

Thu, Mar 4, 2027in 106 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 26 – Mar 19

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$0.00
Revenue, change from a year earlier: Q3 2026 −100.0%, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
Net income
-$12.59M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026$0.00−100.0% vs Q3 2025

Latest results

  1. Q3 2026Nov 5, 2026, before the openThe release13.5%by the close of Nov 5
    Revenue
    $0.00
    −100.0%
    Net income
    -$25.20M
    N/M
    EPS
    -$0.14
    N/M
    Initiated the RECEPTIVE-CD1 Phase 2b clinical trial of SL-325 in patients with moderately-to-severely active Crohn's disease.
  2. Q2 2026Aug 11, 2026, before the openThe release+0.2%by the close of Aug 11
    Revenue
    $0.00
    —
    Net income
    -$15.15M
    N/M
    EPS
    -$0.12
    N/M
  3. Q1 2026May 7, 2026, before the openThe release6.4%by the close of May 7
    Revenue
    $0.00
    —
    Net income
    -$14.77M
    N/M
    EPS
    -$0.13
    N/M
  4. Q4 2025Mar 5, 2026, before the openThe release+8.1%by the close of Mar 5
    Revenue
    $0.00
    —
    Net income
    -$12.59M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 5, 2026 · pre-marketNov 5, 202636 d10-Q$0.00−100.0%-$0.1413.5%
Q2 2026Jun 30, 2026Aug 11, 2026 · pre-marketAug 11, 202642 d10-Q$0.00—-$0.12+0.2%
Q1 2026Mar 31, 2026May 7, 2026 · pre-marketMay 7, 202637 d10-Q$0.00—-$0.136.4%
FY 2025
Q4 2025derivedDec 31, 2025Mar 5, 2026 · pre-marketMar 5, 202664 d10-K$0.00——+8.1%
Q3 2025Sep 30, 2025Nov 6, 2025 · after-hoursNov 6, 202537 d10-Q$1.00M−66.6%-$0.14+2.6%
Q2 2025Jun 30, 2025Aug 14, 2025 · pre-marketAug 14, 202545 d10-Q$0.00−100.0%-$0.24+7.9%
Q1 2025Mar 31, 2025May 1, 2025 · after-hoursMay 1, 202531 d10-Q$0.00−100.0%-$0.276.5%
FY 2024
Q4 2024derivedDec 31, 2024Mar 27, 2025 · pre-marketMar 27, 202586 d10-K$0.00−100.0%—3.4%
Q3 2024Sep 30, 2024Nov 14, 2024 · pre-marketNov 14, 202445 d10-Q$3.00M+336.9%-$0.33+11.7%
Q2 2024Jun 30, 2024Aug 1, 2024 · after-hoursAug 1, 202432 d10-Q$1.61M+704.5%-$0.42—
Q1 2024Mar 31, 2024May 2, 2024 · pre-marketMay 2, 202432 d10-Q$1.12M+1,856.1%-$0.37—
Earlier years, FY 2019 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 5, 2026070618
10-QAug 11, 2026055483
10-QMay 7, 2026031661
10-KMar 5, 2026014989
10-QNov 6, 2025000057
10-QAug 14, 2025000046
10-QMay 1, 2025000034
10-KMar 27, 2025000012
10-QNov 14, 2024000053
10-QAug 1, 2024000040

Provenance

ProvenanceData status and checks

Shattuck Labs, Inc. · CIK 1680367 · Engraved from SEC EDGAR